Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Study of Suberoylanilide Hydroxamic Acid (SAHA) in Subjects With Locally Advanced, Recurrent or Metastatic Adenoid Cystic Carcinoma (ACC)

NCT01175980 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT01175980
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01175980 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Study of Suberoylanilide Hydroxamic Acid (SAHA) in Subjects With Locally Advanced, Recurrent or Metastatic Adenoid Cystic Carcinoma (ACC)
Lead sponsor
National Cancer Institute (NCI)
Phase
Phase 2
Overall status
Completed
Start date
August 6, 2010
Completion date
August 1, 2018
Enrollment
30 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent oral cavity adenoid cystic carcinoma, recurrent salivary gland carcinoma, salivary gland adenoid cystic carcinoma, stage iii major salivary gland cancer ajcc v7, stage iii oral cavity adenoid cystic carcinoma ajcc v6 and v7, stage iva major salivary gland cancer ajcc v7, stage iva oral cavity adenoid cystic carcinoma ajcc v6 and v7, stage ivb major salivary gland cancer ajcc v7, stage ivb oral cavity adenoid cystic carcinoma ajcc v6 and v7, stage ivc major salivary gland cancer ajcc v7, stage ivc oral cavity adenoid cystic carcinoma ajcc v6 and v7, tongue carcinoma